Incyte Corporation (INCY) has a market capitalization of $19.44B and trades at $97.69. The 52-week range is 53.56-112.29.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 14.8, Earnings Per Share (EPS) of $6.59, annual revenue of $5.14B.
The stock has a beta of 0.86, operates in the Healthcare sector.
